🔴 Tenaya Therapeutics is trading 5% down today as Treasury yields reached post-2007 highs

Tenaya Therapeutics is trading at $0.63, down 5.29% on September 24, 2026, with the decline appearing tied primarily to biotech-sector weakness and broader risk-off trading.

• No new company-specific announcement was identified during this session.
• The FDA RMAT designation for TN-401 was announced on September 14, not during this session.
• Treasury yields reached post-2007 highs amid strong PMI data, oil-price concerns, and renewed rate fears.